RBM19 antibody
Principal name
RBM19 antibody
Alternative names for RBM19 antibody
RNA-binding protein 19, KIAA0682, RNA-binding motif protein 19
Ncbi ID
9606, NP_001140170.1, NP_057280.1, NM_016196, NM_001146698, NM_001146699, NP_057280, NM_028762
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB)
Background of RBM19 antibody
- Kit Component:
- - KN202568G1, KIAA0682 gRNA vector 1 in pCas-Guide vector
- KN202568G2, KIAA0682 gRNA vector 2 in pCas-Guide vector
- KN202568D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP302568 | RBM19 |
||||
| Recombinant protein of human RNA binding motif protein 19 (RBM19) | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€788.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY414130 | RBM19 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY432072 | RBM19 overexpression lysate |
|
![]() |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. | ||
| LY432073 | RBM19 overexpression lysate |
|
![]() |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR211289L2V | Lenti ORF particles, Rbm19 (GFP-tagged) - Mouse RNA binding motif protein 19 (Rbm19), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,810.00
|
|
| OriGene Technologies, Inc. | ||
| MR211289L1V | Lenti ORF particles, Rbm19 (Myc-DDK-tagged) - Mouse RNA binding motif protein 19 (Rbm19), 200 uL, >10^7 TU/mL |
|
![]() |
200 µl /
€1,630.00
|
|
| OriGene Technologies, Inc. | ||


